¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Transient neonatal myasthenia gravis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® myasthenia gravis ÇÑ±Û ÁßÁõ±ÙÀ°¹«·ÂÁõ
¼³¸í   
  È°µ¿½Ã¿¡ ±Ù´ë¾à°ú ÇǷθ¦ È£¼ÒÇÏ´Ù°¡ ¾ÈÁ¤ ÈÄ¿¡´Â È¸º¹µÇ´Â Æ¯Â¡ÀûÀΠÁõ»óÀ» È£¼ÒÇϴ º´À¸·Î, ±ÙÀ°°ú ½Å°æÁ¢ÇպΠ»çÀÌ ¿¬°áºÎºÐ ÀÌ»óÀ¸·Î ¹ß»ýÇÑ´Ù. ÁַΠÀþÀº ¿©¼º¿¡¼­ ºó¹ßÇϰí, ´«ÁÖÀ§ ±ÙÀ°À» Àߠħ¹üÇÑ´Ù. ´ë°³ ¾ÆÄ§À̳ª È޽ĠÈÄ¿¡´Â È£ÀüµÇ¾ú´Ù°¡ ¿îµ¿½Ã ¾ÇÈ­µÇ´Â ÇÇ·ÎÇö»óÀ» º¸ÀδÙ. ¸ÞÄ¿´ÏÁòÀº ¾Æ¸¶ ¸é¿ª°èÀÇ ÀÌ»óÀ¸·Î ÀÎÇØ ¹ß»ýÇϴ °ÍÀ¸·Î º¸À̸ç, Ä¡·á ¶ÇÇÑ ¸é¿ªÀ» ¾ïÁ¦Çϴ ¾àÀ» ´Ù·® Åõ¿©ÇÔÀ¸·Î½á È£ÀüµÇ¾ú´Ù´Â º¸°í°¡ ¸¹´Ù. Ä§¹üºÎÀ§ÀÇ ±ÙÀ°¿¡ µû¶ó ¿©·¯ °¡Áö Á¾·ù°¡ ÀÖÀ¸¸ç, È£Èí±Ù±îÁö Ä§¹üÇϰԠµÇ¸é, È£Èí±â´É»ó½Ç·Î »ç¸ÁÇÑ´Ù. ½Å°æ-±ÙÀ° Á¢ÇպΠÁß Á¢ÇÕµÚ¸·ÀÇ ¾Æ¼¼Æ¿Äݸ° ¼ö¿ëüÀÇ Àå¾Ö°¡ ¹ß»ýÇϴ ÀÚ°¡¸é¿ªº´ÀÌ´Ù. µû¶ó¼­ ½Å°æ-±ÙÀ° Á¢Çպο¡¼­ ½Å°æÀڱؠÀü´ÞÀÌ Â÷´ÜµÇ¾î ±ÙÀ°¼è¾à°ú Á¶±â ÇǷΰ¡ ¿Â´Ù. È¯ÀÚÀÇ 85~90%¿¡¼­ Ç÷Áß¿¡ ¾Æ¼¼Æ¿Äݸ° ¼ö¿ëü¿¡ ´ëÇÑ Ç×ü°¡ ÀÖ´Ù. ÀüÀÚÇö¹Ì°æÀ¸·Î °üÂû½Ã ½Å°æ ±ÙÀ° Á¢ÇպΠÁ¢ÇÕÁÖ¸§ °¨¼Ò ¹× ´Ü¼øÈ­¸¦ º¸ÀδÙ. È¯ÀÚÀÇ 15~50%´Â °¡½¿»ùÁ¾°ú µ¿¹ÝµÇ°í ³ª¸ÓÁö´Â °¡½¿»ù°ú´ÙÇü¼º°ú Àß µ¿¹ÝµÈ´Ù. ±¤ÇÐÇö¹Ì°æ»ó¿¡¼­´Â 2Çü ±ÙÀ°¼¶À¯ÀÇ À§Ãà°ú Å»½Å°æ¿¡ ÀÇÇÑ ÀÛ°í °¢Áø ±ÙÀ°¼¶À¯°¡ ³ªÅ¸³ª´Â °Í À̿ܿ¡´Â Æ¯º°ÇÑ ¼Ò°ßÀ» º¸ÀÌÁö ¾Ê´Â´Ù.
¿µ¹® neonatal intensive care center ÇÑ±Û ½Å»ý¾Æ ÁýÁßÄ¡·á½Ç
¼³¸í   
  ¹Ì¼÷¾Æ³ª °¡»ç »óÅÂÀÇ Ãâ»ê¾Æ¸¦ ÁýÁßÀûÀ¸·Î º¸»ìÇǰí Ä¡·áÇϴ ±â°ü.
¿µ¹® transient ischemic attack(TIA) ÇÑ±Û Àϰú¼ºÇãÇ÷¹ßÀÛ
¼³¸í   
  ³úÇ÷°ü Æó¼â¿¡ ÀÇÇÑ Àϰú¼ºÀÇ ½Ç½Å, µÎÅë, ½Ã·Â»ó½Ç µîÀÇ Áõ¼¼¸¦ º¸À̴ »óÅ·Π24½Ã°£ À̳»¿¡ ¸ðµç Áõ»óÀ̠ȸº¹µÇ´Â °æ¿ì¸¦ ¸»ÇÑ´Ù. ÈÄ¿¡ ¿µ±¸ÀûÀΠ³úÇãÇ÷ Áï ³ú°æ»öÁõÀÌ ¿Ã °¡´É¼ºÀÌ ¸Å¿ì ³ô¾ÆÁø´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myasthenia gravis
    ÁßÁõ±Ù(À°)¹«·ÂÁõ
  • myasthenia
    ±Ù(À°)¹«·ÂÁõ
  • icterus gravis
    ÁßÁõȲ´Þ
  • icterus gravis neonatorum
    ½Å»ý¾ÆÁßÁõȲ´Þ
  • early neonatal mortality rate
    Á¶±â½Å»ý¾Æ»ç¸Á·ü
  • neonatal
    ½Å»ý¾Æ-
  • neonatal alloimmune thrombocytopenia
    ½Å»ý¾Æµ¿Á¾¸é¿ªÇ÷¼ÒÆÇ°¨¼Ò(Áõ)
  • neonatal anemia
    ½Å»ý¾ÆºóÇ÷
  • neonatal asphyxia
    ½Å»ý¾ÆÁú½Ä
  • neonatal atelectasis
    ½Å»ý¾Æ¹«±âÆó
  • neonatal blennorrhea
    °«³­¾Ö°í¸§´«¹°, ½Å»ý¾Æ³ó·ç
  • neonatal death
    ½Å»ý¾Æ»ç¸Á
  • neonatal death rate
    ½Å»ý¾Æ»ç¸Á·ü
  • neonatal diarrhea
    ½Å»ý¾Æ¼³»ç
  • neonatal epilepsy
    ½Å»ý¾Æ°£Áú
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myasthenia gravis
    ÁßÁõ±ÙÀ°¹«·ÂÁõ
  • transient ischemic attack
    Àϰú¼ºÇãÇ÷¹ßÀÛ
  • myasthenia
    ±ÙÀ°¹«·ÂÁõ
  • transient
    Àϰú¼º-
  • neonatal intensive care center
    ½Å»ý¾ÆÁýÁßÄ¡·á½Ç
  • neonatal death
    ½Å»ý¾Æ»ç¸Á
  • neonatal hepatitis
    ½Å»ý¾Æ°£¿°
  • neonatal infection
    °«³­¾Ö°¨¿°, ½Å»ý¾Æ°¨¿°
  • neonatal mortality
    ½Å»ý¾Æ»ç¸Á·ü
  • neonatal period
    ½Å»ý¾Æ±â
  • neonatal screening
    ½Å»ý¾Æ¼±º°°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myasthenia gravis
    (¢¡gravis) ÁßÁõ±ÙÀ°¹«·ÂÁõ
  • transient familial neonatal hyperbilirubinemia
    Àϰú¼º°¡Á·½Å»ý¾Æ°íºô¸®·çºóÇ÷Áõ
  • transient neonatal pustular melanosis
    Àϰú¼º½Å»ý¾Æ°í¸§¹°ÁýÈæ»öÁõ
  • myasthenia
    ±ÙÀ°¹«·ÂÁõ
  • myasthenia ocularis
    ´«±ÙÀ°¹«·ÂÁõ
  • icterus gravis
    ÁßÁõȲ´Þ
  • icterus gravis neonatorum
    ½Å»ý¾ÆÁßÁõȲ´Þ
  • mania gravis
    ÁßÁ¶º´
  • melancholia gravis
    ÁßÁõ¿ì¿ïº´
  • transient ischemic attack
    Àϰú¼ºÇãÇ÷¹ßÀÛ
  • transient acantholytic dermatosis
    Àϰú¼º°¡½Ã¼¼Æ÷ÇØ¸®ÇǺκ´
  • transient flora
    ¶°µ¹À̱չ«¸®
  • transient glycosuria
    Àϰú¼º´ç´¢
  • transient hypogammaglobulinemia
    Àϰú¼ºÀú°¨¸¶±Û·ÎºÒ¸°Ç÷Áõ
  • transient cerebral ischemia
    Àϰú¼º³úÇãÇ÷Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • MG=£¾myasthenia gravis
    ÁßÁõ±Ù¹«·ÂÁõ.
  • MG=£¾myasthenia gravis
    ÁßÁõ ±Ù¹«·ÂÁõ.
  • Grovers disease => transient acantholytic dermatosis
    Àϰú¼º ±Ø¼¼Æ÷ÇØ¸® ÇǺÎÁõ
  • TIA=£¾transient ischemic attack
    Àϰú¼º ÇãÇ÷¹ßÀÛ, Àϰú¼º ºóÇ÷¹ßÀÛ.
  • hypogammaglobulinemia, transient
    Àϰú¼º °¨¸¶±Û·ÎºÒ¸°ÀúÇ÷Áõ
  • icterus gravis
    ÁßÁõȲ´Þ(ñìñø)
  • icterus gravis neonatorum ³ª
    ½Å»ý¾ÆÁßÁõ (¼º) Ȳ´Þ(ãæßæä®ñìñøàõüÜÓ¸).
  • icterus gravis ³ª
    ÁßÁõ(¼º) Ȳ´Þ(ñìñøàõüÜ Ó¸).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myasthenia gravis
    ÁßÁõ(ñìñø) ±Ù¹«·ÂÁõ
  • myasthenia gravis juvenilis ³ª
    ¿¬¼Ò¼º ÁßÁõ ±Ù¹«·ÂÁõ.
  • myasthenia gravis pseudoparalytica ³ª
    °¡¼º¸¶ºñ¼º ÁßÁõ±Ù¹«·ÂÁõ.
  • myasthenia gravis syndrome ³ª
    ÁßÁõ±Ù¹«·ÂÁõÈıº(ýªÔéÐÉÙëæ³ñø).
  • transient familial neonatal hyperbilirubinemia
  • transient neonatal pustular melanosis
    Àϰú¼º ½Å»ý¾Æ ³óÆ÷ ¸á¶ó´Ñ»ö¼ÒÁõ
  • transient neonatal pustulosis
    Àϱ¤¼º ½Å»ý¾Æ ³óÆ÷Áõ
  • asthenia gravis hypophyseogenea<³ª>
    ³úÇϼöü¼º ÁßÁõ¹«·Â(Áõ).
  • epilepsia gravis et mitis<³ª>
    Áß°æÁõ(ñìÌîñø)°£Áú.
  • icterus gravis
    ÁßÁõȲ´Þ(ñìñø)
  • icterus gravis neonatorum ³ª
    ½Å»ý¾ÆÁßÁõ (¼º) Ȳ´Þ(ãæßæä®ñìñøàõüÜÓ¸).
  • icterus gravis ³ª
    ÁßÁõ(¼º) Ȳ´Þ(ñìñøàõüÜ Ó¸).
  • intestinitis gravis
    ÁßÁõÀå¿°(ñìñøíóæú).
  • mania gravis ³ª
    ÁßÁ¶Áõ(ñìðâñø).
  • melancholia gravis ³ª
    ÁßÁõ¿ì¿ïÁõ.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Neonatal period
    ½Å»ý¾Æ±â
    [¿¾ ¿ë¾î] ½Å»ý¾Æ±â
  • Neonatal line
    ù¼ºÀå¼±
    [¿¾ ¿ë¾î] ½Å»ý¼±
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chromatic transient
    »ö±¤°úµµ¼º(ßäÎÊΦԳàõ)
  • transient dipole-induced dipole interactions
    °úµµ ½Ö±ØÀÚÀ¯µµ ½Ö±ØÀÚ »óÈ£ ÀÛ¿ë(ΦԤäªÐ¿í­ ë¯ÓôäªÐ¿í­ßÓû»íÂéÄ)
  • transient equilibrium
    °úµµÆòÇü(ΦԤøÁû¬)
  • transient phase
    °úµµ»ó(ΦԤßÒ)
  • transient state isoelectric focusing
    °úµµ»óÅÂ(ΦԤßÒ÷¾) µîÀü(Ôõï³)Æ÷Ä¿½Ì
  • transient state kinetics
    °úµµ»óÅ ¿ªÇÐ(ΦԤßÒ÷¾ÕôùÊ)
  • transient time
    °úµµ±â ½Ã°£(ΦԤѢãÁÊà)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myasthenia gravis
    ÁßÁõ±Ù¹«·ÂÁõ
  • transient
    Àϰú¼ºÀÇ
  • neonatal
    ½Å»ý¾ÆÀÇ, ½Å»ý¾Æ
  • neonatal atelectasis
    ½Å»ý¾Æ¹«±âÆó
  • neonatal jaundice
    ½Å»ý¾ÆÈ²´Þ
  • neonatal mortality
    ½Å»ý¾Æ»ç¸Á(·ü)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MG   1) Myasthenia Gravis
  2) MonoGlyceride
  3) Monoclonal Gammop...
CMG canine or congenital myasthenia gravis; chopped meat glucose [medium]; cystometrography, cystometrog...
EAMG experimental autoimmune myasthenia gravis
FIMG familial infantile myasthenia gravis
JAMG juvenile autoimmune myasthenia gravis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EAMG Experimental Autoimmune Myasthenia Gravis
MG MYASTHENIA GRAVIS
TNDM Transient neonatal diabetes mellitus
BFNC Benign Familial Neonatal Convulsions
BNBAS Brazelton Neonatal Behavioral Assessment Scale
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • P94.0
    Transient neonatal myasthenia gravis
    Àϰú¼º ½Å»ý¾Æ ÁßÁõ ±ÙÀ°¹«·ÂÁõ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • myasthenia gravis syndrome
    ÁßÁõ ±Ù¹«·Â ÁõÈıº
  • icterus gravis
    ÁßÁõ Ȳ´Þ, ÁßÁõ¼º Ȳ´Þ
  • myasthenia gastrics
    À§ ±Ù ¹«·ÂÁõ
  • myasthenia ocularis
    ¾È±Ù ¹«·ÂÁõ
  • transient acantholytic dermatosis
    Àϰú¼º ±Ø¼¼Æ÷ ÇØ¸® ÇǺκ´
  • transient cerebral ischemia
    ÀϽÃÀû ³ú ÇãÇ÷
  • transient hypothyroidism
    ÀϽÃÀû °©»ó¼± ±â´É ºÎÀüÁõ
  • neonatal
    ½Å»ý¾ÆÀÇ, ½Å»ý¾Æ
    µ¿ÀǾî=neonate. Ãâ»ý ÈÄ Ã³À½ 4ÁÖ¸¦ ¾ð±Þ.
  • neonatal alloimmune thrombocytopenia
    ½Å»ý¾Æ µ¿Á¾ ¸é¿ª Ç÷¼ÒÆÇ °áÇÌÁõ
  • neonatal anesthesia
    ½Å»ý¾Æ ¸¶Ãë
  • neonatal asphyxia
    ½Å»ý¾Æ °¡»ç, ½Å»ý¾Æ Áú½Ä
  • neonatal blennorrhea
    ½Å»ý¾Æ ¾È ³ó·ç
  • neonatal calf diarrhea corona virus
    ½Å»ý¾Æ ¼³»ç Äڷγª ¹ÙÀÌ·¯½º
  • neonatal death
    ½Å»ý¾Æ »ç¸Á
  • neonatal diarrhea
    ½Å»ý¾Æ ¼³»ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
myasthenia gravis <disease, neurology> The characteristic feature of the disease is easy fatigue of certain voluntary muscle groups on repeated use. Muscles of the face or upper trunk are especially likely to be affected. In most and perhaps all cases due to the development of autoantibodies against the acetylcholine receptor in neuromuscular junctions. Immunisation of mice or rats with this receptor protein leads to a disease with the features of myasthenia.
(18 Nov 1997)
myasthenia gravis and thymoma <radiology> Of patients with MG 15% have thymoma, of patients with thymoma 50% have MG
(12 Dec 1998)
myasthenia <anatomy, neurology> Muscular debility, any constitutional anomaly of muscle.
Origin: Gr. Astheneia = weakness
(18 Nov 1997)
myasthenia angiosclerotica <symptom> A symptom complex characterised by leg pain and weakness brought on by walking, with the disappearance of the symptoms following a brief rest.
(12 Dec 1998)
anaemia gravis <haematology> This form of anaemia occurs when the bone marrow ceases sufficient red and white blood cell production. It may be induced by exposures to high levels of toxic chemicals, radiation and certain drugs.
It is generally unresponsive to specific therapy, often accompanied by granulocytopenia and thrombocytopenia, in which the bone marrow may not necessarily be hypocellular or hypoplastic but fails to produce adequate numbers of peripheral blood elements. The term actually is all inclusive and most probably encompasses several clinical syndromes.
Origin: Gr. Haima = blood
(29 Sep 1997)
colitis gravis An obsolete term for ulcerative colitis.
(05 Mar 2000)
neurasthenia gravis A condition of extreme and lasting neurasthenia.
(05 Mar 2000)
icterus gravis Jaundice associated with high fever and delirium; seen in severe hepatitis and other diseases of the liver with severe functional failure.
Synonym: malignant jaundice.
(05 Mar 2000)
oneirodynia gravis 1. A fiend or incubus formerly supposed to cause trouble in sleep.
2. A condition in sleep usually caused by improper eating or by digestive or nervous troubles, and characterised by a sense of extreme uneasiness or discomfort (as of weight on the chest or stomach, impossibility of motion or speech, etc), or by frightful or oppressive dreams, from which one wakes after extreme anxiety, in a troubled state of mind; incubus.
3. Hence, any overwhelming, oppressive, or stupefying influence.
Origin: Night + mare incubus. See Mare incubus.
Source: Websters Dictionary
(01 Mar 1998)
cerebral ischemia, transient Nonconvulsive, reversible, focal neurologic deficits lasting minutes up to about 24 hours, resulting mainly from arteriosclerosis, emboli, or hypertensive episodes.
(12 Dec 1998)
transient 1. Short-lived; passing; not permanent; said of a disease or an attack.
2. A short-lived cardiac sound having little duration (less than 0.12 second) as distinct from a murmur; e.g., first, second, third, and fourth heart sounds, clicks, and opening snaps.
Origin: L. Transeo, pres. P. Transiens, to cross over
(05 Mar 2000)
transient acantholytic dermatosis A pruritic papular eruption, with histologic suprabasal acantholysis, of the chest, with scattered lesions of the back and lateral aspects of the extremities, lasting from a few weeks to several months; seen predominantly in males over 40.
Synonym: Grover's disease.
(05 Mar 2000)
transient agammaglobulinaemia A type of primary immunodeficiency that occurs in infants of both sexes, usually before the sixth month of life, probably resulting from immaturity of lymphoid tissue.
Synonym: transient agammaglobulinaemia.
(05 Mar 2000)
transient albuminuria Albuminuria of a temporary or short-lived nature.
(05 Mar 2000)
transient global amnesia A memory disorder seen in middle aged and elderly persons characterised by an episode of amnesia and bewilderment which persists for several hours; during the episode the patient has a memory defect for present and recent past events, but is fully alert, oriented, capable of high-level intellectual activity, and has a normal neurological examination. Typically, these amnesic episodes occur spontaneously, and most patients experience only one; of uncertain aetiology-probably ischemic, but not due to atherosclerosis.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neonatal
    ½Å»ý¾ÆÀÇ
  • transient
    Áö¼ÓµÇÁö ¾Ê´Â; ¼ø°£ÀûÀÎ;µ¡¾ø´Â
  • transient
    ÀϽÃÀûÀÎ;µ¡¾ø´Â;´Ü±â ü·ùÀÇ(¼Õ´Ô)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á